Science and technology form a powerful and mutually reinforcing partnership that drives human progress. Scientific research expands our understanding of the natural world by discovering new principles, laws, and phenomena, while technology applies this knowledge to create practical tools, systems, and solutions that improve everyday life. In turn, technological advances provide scientists with increasingly sophisticated instruments—such as high-resolution microscopes, powerful computers, and advanced sensors—that enable deeper and more precise exploration of complex scientific questions. This continuous feedback loop accelerates innovation across fields ranging from medicine and energy to communication and space exploration. As global challenges such as climate change, health crises, and sustainable development become more pressing, the synergy between science and technology becomes even more essential, transforming knowledge into tangible benefits for society and fostering a future driven by discovery, creativity, and practical impact.

The synergy between science and technology is crucial for advancing cancer diagnosis and treatment. Scientific discoveries in tumor biology and cellular mechanisms provide the knowledge needed to understand how cancers develop and progress, while technological innovations translate this knowledge into powerful diagnostic and therapeutic tools. Advanced imaging systems, molecular spectroscopy, and minimally invasive medical devices now enable earlier detection and more precise characterization of tumors. At the same time, technologies such as targeted therapies, image-guided surgery, and plasma-based treatments allow clinicians to treat cancer with greater accuracy and reduced damage to healthy tissue. Together, science and technology accelerate the development of more effective, personalized approaches to cancer care.

Several emerging technologies illustrate how real-time optical biopsy and cold plasma can improve cancer diagnosis and treatment.

Real-time optical biopsy techniques enable clinicians to identify malignant tissue without removing a physical sample. For example, Confocal Laser Endomicroscopy allows microscopic imaging of tissue directly inside the body during endoscopy, providing near-histological resolution in real time. Optical Coherence Tomography produces cross-sectional images of tissue microstructure and is widely investigated for detecting early epithelial cancers. Spectroscopic approaches such as Raman Spectroscopy and Coherent Anti‑Stokes Raman Scattering can also identify biochemical signatures of tumors, enabling rapid and label-free tissue characterization during clinical procedures.

For treatment, cold atmospheric plasma technologies generate reactive oxygen and nitrogen species that can selectively damage cancer cells while sparing surrounding healthy tissue. Devices such as the kINPen MED and PlasmaDerm have been clinically explored for biomedical applications, including tumor treatment and wound healing. Plasma can induce oxidative stress, trigger apoptosis in cancer cells, and may also stimulate anti-tumor immune responses, making it a promising complementary approach for localized cancer therapy.

A promising future direction in oncology is the integration of real-time optical biopsy with cold atmospheric plasma therapy into a single image-guided treatment platform. Optical biopsy techniques such as Raman Spectroscopy, Coherent Anti-Stokes Raman Scattering, Optical Coherence Tomography, and Confocal Laser Endomicroscopycan rapidly identify malignant tissue and delineate tumor margins at the microscopic level during endoscopic procedures. Once suspicious regions are detected, a localized Cold Atmospheric Plasma source can be immediately activated to deliver reactive species directly to the identified tumor area.

Such a closed-loop approach would allow diagnosis, treatment, and verification in the same procedure. Real-time imaging could guide the precise positioning of the plasma source, ensuring that treatment is confined to malignant tissue while sparing healthy structures. After plasma exposure, the same optical modalities could reassess the treated region to evaluate biochemical and structural changes in the tissue, providing immediate feedback on treatment efficacy.

Integrating these technologies within a fiber-based endoscopic platform could enable minimally invasive, highly targeted cancer therapy. This strategy has the potential to reduce the need for conventional biopsies, shorten clinical workflows, and support personalized, image-guided cancer treatment, where diagnosis and therapy are seamlessly combined in real time. 

Conclusions and future perspectives

The discussion highlighted the strong synergy between science and technology in advancing cancer diagnosis and treatment. A key focus was the development of real-time optical biopsy, which enables immediate identification of malignant tissue during clinical procedures using techniques such as Raman Spectroscopy, Coherent Anti-Stokes Raman Scattering, Optical Coherence Tomography, and Confocal Laser Endomicroscopy. These methods provide label-free, high-resolution information on tissue structure and biochemical composition, enabling earlier and more precise tumor detection.

Another important element is Cold Atmospheric Plasma, a promising therapeutic approach that generates reactive species capable of selectively damaging cancer cells while minimizing harm to surrounding healthy tissue.

A key perspective emerging from the discussion is the integration of diagnosis and therapy into a single platform. By combining optical biopsy with plasma delivery in an endoscopic or fiber-based system, clinicians could detect tumors in real time, immediately apply localized plasma treatment, and then reassess the treated area with the same optical tools. This closed-loop strategy could enable minimally invasive, highly targeted, and more personalized cancer care.